SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-01-28
Tx date 2019-01-25 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+1,246,092 vol 		13,870,849
Filed 2019-01-28
Tx date 2019-01-25 		$KALY
Kalytera Therapeutics, Inc. 		Rudman, Victoria Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+300,000 vol 		897,360
Filed 2019-01-28
Tx date 2019-01-25 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,129,318 vol 		3,761,618
Filed 2019-01-28
Tx date 2019-01-25 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
+1,129,318 vol 		4,141,083
Filed 2018-09-27
Tx date 2018-09-24 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,262,475 vol 		2,632,300
Filed 2018-09-27
Tx date 2018-09-24 		$KALY
Kalytera Therapeutics, Inc. 		Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,262,475 vol 		1,758,941
Filed 2018-09-27
Tx date 2018-09-24 		$KALY
Kalytera Therapeutics, Inc. 		Rudman, Victoria Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+250,000 vol 		597,360
Filed 2018-09-27
Tx date 2018-09-24 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
+1,262,475 vol 		3,011,765
Filed 2018-09-27
Tx date 2018-09-24 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+5,117,794 vol 		12,624,757
Filed 2018-01-31
Tx date 2018-01-30 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+326,000 vol 		1,369,825
Filed 2018-01-31
Tx date 2018-01-30 		$KALY
Kalytera Therapeutics, Inc. 		Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+326,000 vol 		496,466
Filed 2018-01-31
Tx date 2018-01-30 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+1,045,210 vol 		7,506,963
Filed 2018-01-31
Tx date 2018-01-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
+326,000 vol 		1,749,290
Filed 2017-12-06
Tx date 2017-10-08 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options
+1,022,610 vol 		1,423,290
Filed 2017-12-06
Tx date 2017-10-08 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+5,473,442 vol 		6,461,753
Filed 2017-12-06
Tx date 2017-10-08 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,022,610 vol
Filed 2017-12-06
Tx date 2017-10-08 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,022,610 vol
Filed 2017-12-06
Tx date 2017-10-08 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+681,740 vol 		1,043,825
Filed 2017-12-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+308,764 vol 		308,764
Filed 2017-12-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+304,764 vol
Filed 2017-12-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+304,764 vol
Filed 2017-12-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+308,764 vol 		308,764
Filed 2017-01-11
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-11
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-11
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-11
Tx date 2017-01-09 		$KALY
Kalytera Therapeutics, Inc. 		Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+170,466 vol 		170,466
Filed 2017-01-11
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Zeldis, Jerome
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+168,277 vol 		426,688
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Farrell, Robert Edward
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+988,311 vol 		988,311
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Salzman, Andrew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Salzman, Andrew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+746,702 vol 		746,702
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Salzman, Andrew
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+3,180,699 vol 		3,927,401
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Stefansky, David
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Bezalel Partners LLC (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Stefansky, David
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Bezalel Partners LLC (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+3,813,229 vol 		3,813,229
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Stefansky, David
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Stefansky, David
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+193,808 vol 		193,808
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Stefansky, David
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+415,288 vol 		609,096
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Stefansky, David
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+849,100 vol 		1,458,196
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Yakatan, Seth
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Sutherland Paige & Associates Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Yakatan, Seth
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Sutherland Paige & Associates Inc. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+771,909 vol 		771,909
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Yakatan, Seth
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Yakatan, Seth
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+193,808 vol 		193,808
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Yakatan, Seth
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+247,011 vol 		440,819
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Yakatan, Seth
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+674,561 vol 		1,115,380
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Zeldis, Jerome
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-09
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Zeldis, Jerome
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+258,411 vol 		258,411
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Rudman, Victoria Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+115,787 vol 		347,360
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Rudman, Victoria Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+231,573 vol 		231,573
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Rudman, Victoria Diana
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+168,277 vol 		362,085
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+193,808 vol 		193,808
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		paley, jeffrey
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+206,872 vol 		400,680
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+193,808 vol 		193,808
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+304,764 vol 		304,764
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust II (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+304,764 vol 		304,764
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Holder: Rutkowski Family Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
+64,441 vol 		64,441
Filed 2017-01-06
Tx date 2016-12-30 		$KALY
Kalytera Therapeutics, Inc. 		Erickson, Ronald Peter
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report